H31.122
Diffuse secondary atrophy of choroid, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse secondary atrophy of the choroid is a condition characterized by the thinning or loss of tissue in the choroid layer of the eye, which supplies blood to the retina. When this atrophy occurs in the left eye, it can affect vision and eye health. This condition is often linked to underlying eye disorders or systemic diseases and requires careful attention for diagnosis and management.
Causes & Symptoms
Clinical Causes: Age-related changes leading to tissue degeneration Chronic inflammatory conditions affecting the eye Degenerative diseases such as choroidal sclerosis Previous eye injuries or surgeries Systemic illnesses like autoimmune diseases Infections that cause inflammation or damage to eye tissues High myopia or extreme nearsightedness Genetic predispositions influencing eye tissue health
Key Symptoms: Gradual or sudden loss of vision in the affected eye Visual distortions such as blurriness or distorted images Reduced ability to perceive fine details Presence of dark or shadowy areas in the visual field Possible increased sensitivity to light No significant symptoms in early stages, making regular eye check-ups important
Diagnostic & Treatment
Diagnosis Path: Detailed medical history review focusing on ocular and systemic health Visual acuity tests to assess clarity of vision Fundus examination using an ophthalmoscope to observe choroidal thinning Imaging studies such as optical coherence tomography (OCT) for detailed cross-sectional images of the retina and choroid Fluorescein angiography to evaluate blood flow and vessel integrity in the choroid Additional tests as needed depending on suspected underlying causes
Treatment Protocols: Regular monitoring and follow-up appointments with an eye specialist Managing underlying systemic or ocular conditions to slow progression Protecting the eyes from further damage through UV protection and avoiding eye strain Use of corrective lenses to optimize vision, if necessary Advanced therapies such as anti-vascular endothelial growth factor (anti-VEGF) injections may be considered if abnormal blood vessels develop Low vision aids and rehabilitation to help adapt to vision loss Research into regenerative therapies is ongoing but not yet widely available
Clinical Advice & FAQs
Billing Guidance
Is H31.122 a billable ICD-10 code?
Yes, H31.122 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H31.122?
Clinical documentation must specify the nature of Diffuse secondary atrophy of choroid, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference